NPPA Approves Separate Price for GSK's New Paracetamol-Phenylephrine Sachet Parthika Patel29 July 2025 10:12 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has...
Roche Slammed for Seeking Zydus' Confidential Process for Cancer Drug Sigrima Without Meeting Patent Threshold Farhat Nasim28 July 2025 6:29 PM ISTNew Delhi: In a major relief to Zydus Lifesciences, the Delhi High Court dismissed F. Hoffmann-La Roche's plea seeking disclosure of Zydus'...
Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed Farhat Nasim27 July 2025 1:00 PM ISTNew Delhi: In the aftermath of the fatal explosion at Escientia Advanced Sciences Pvt. Ltd. in Anakapalli, Andhra Pradesh, the Parliament was recently...
NPPA Committee Asks Intas to Clarify Patent Discrepancy in Clozapine ER Pricing Plea Parthika Patel26 July 2025 8:47 PM ISTNew Delhi: The Multidisciplinary Committee (MDC) of Experts under the National Pharmaceutical Pricing Authority (NPPA) has asked Intas Pharmaceuticals...
No Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic Formulation Farhat Nasim25 July 2025 5:24 PM ISTNew Delhi: In a regulatory pushback against what it deemed an ineligible pricing request, the Multi-Disciplinary Committee (MDC) of the National...
NPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge Farhat Nasim24 July 2025 6:54 PM ISTNew Delhi: In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under India's drug...
Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026 Farhat Nasim23 July 2025 4:45 PM ISTNew Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC Parthika Patel22 July 2025 6:19 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules Farhat Nasim21 July 2025 11:51 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a revised guidance document detailing the procedure for the issuance of...
State Drug Alert: 130 Batches Found Not of Standard Quality in June; No Data Received from Delhi, Gujarat, UP Farhat Nasim20 July 2025 5:36 PM ISTNew Delhi: Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...
CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List Inside Farhat Nasim19 July 2025 3:00 PM ISTNew Delhi: In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of 55 drug...
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel Review Dr. Divya Colin18 July 2025 9:52 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key revisions to the Phase...
